Sodium 1-(pyridin-2-yl)cyclopropane-1-carboxylate

Catalog No.: 
ACPVIP263
CAS No.: 
2731008-62-9
Molecular Formula: 
C9H8NNaO2
Molecular Weight: 
185.16
Sodium 1-(pyridin-2-yl)cyclopropane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$61.00InquiryInquiry
1g95%$104.00InquiryInquiry
5g95%$372.00InquiryInquiry
10g95%$704.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 1-(pyridin-2-yl)cyclopropane-1-carboxylate
IUPAC Namesodium 1-(pyridin-2-yl)cyclopropane-1-carboxylate
Molecular FormulaC9H8NNaO2
Molecular Weight185.16
SMILESO=C(C1(C2=NC=CC=C2)CC1)[O-].[Na+]
InChI KeyFSWOYYWYGMQKNT-UHFFFAOYSA-M
SynonymCyclopropanecarboxylic acid, 1-(2-pyridinyl)-, sodium salt (1:1)
CAS No.2731008-62-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPVIP263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRBOT526 route compound structure diagram
    ACRBOT5261302580-98-8In Stock
  2. Then
  3. ACPVIP263 route product structure diagram
    ACPVIP2632731008-62-9
Inquiry

2. ACPVIP263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6In Stock
  4. Then
  5. ACPVIP263 route product structure diagram
    ACPVIP2632731008-62-9
Inquiry

3. ACPVIP263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQJXK021 route compound structure diagram
    ACQJXK0211256793-26-6In Stock
  2. Then
  3. ACPVIP263 route product structure diagram
    ACPVIP2632731008-62-9
Inquiry

Comments (0)